These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10354542)

  • 1. Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain.
    Grammas P; Ovase R
    Am J Pathol; 2002 May; 160(5):1583-7. PubMed ID: 12000710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.
    Halliwell B
    Drugs Aging; 2001; 18(9):685-716. PubMed ID: 11599635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and Alzheimer's disease.
    Akiyama H; Barger S; Barnum S; Bradt B; Bauer J; Cole GM; Cooper NR; Eikelenboom P; Emmerling M; Fiebich BL; Finch CE; Frautschy S; Griffin WS; Hampel H; Hull M; Landreth G; Lue L; Mrak R; Mackenzie IR; McGeer PL; O'Banion MK; Pachter J; Pasinetti G; Plata-Salaman C; Rogers J; Rydel R; Shen Y; Streit W; Strohmeyer R; Tooyoma I; Van Muiswinkel FL; Veerhuis R; Walker D; Webster S; Wegrzyniak B; Wenk G; Wyss-Coray T
    Neurobiol Aging; 2000; 21(3):383-421. PubMed ID: 10858586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.
    Walker D; Lue LF
    Curr Neuropharmacol; 2007 Dec; 5(4):232-43. PubMed ID: 19305740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
    Halliday G; Robinson SR; Shepherd C; Kril J
    Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
    Jaturapatporn D; Isaac MG; McCleery J; Tabet N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory substances - a new therapeutic option in Alzheimer's disease.
    Hüll M; Fiebich BL; Schumann G; Lieb K; Bauer J
    Drug Discov Today; 1999 Jun; 4(6):275-282. PubMed ID: 10354542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory drugs: a hope for Alzheimer's disease?
    Hüll M; Lieb K; Fiebich BL
    Expert Opin Investig Drugs; 2000 Apr; 9(4):671-83. PubMed ID: 11060701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs.
    Hüll M; Lieb K; Fiebich BL
    Curr Med Chem; 2002 Jan; 9(1):83-8. PubMed ID: 11860350
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.